MorphoSys AG (MOR)
NASDAQ: MOR · IEX Real-Time Price · USD
17.87
+0.36 (2.06%)
At close: May 2, 2024, 4:00 PM
17.60
-0.27 (-1.51%)
After-hours: May 2, 2024, 4:52 PM EDT
MorphoSys AG Employees
MorphoSys AG had 524 employees on December 31, 2023. The number of employees decreased by 105 or -16.69% compared to the previous year.
Employees
524
Change (1Y)
-105
Growth (1Y)
-16.69%
Revenue / Employee
$505,255
Profits / Employee
-$402,320
Market Cap
2.69B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 524 | -105 | -16.69% |
Dec 31, 2022 | 629 | -103 | -14.07% |
Dec 31, 2021 | 732 | 117 | 19.02% |
Dec 31, 2020 | 615 | 189 | 44.37% |
Dec 31, 2019 | 426 | 97 | 29.48% |
Dec 31, 2018 | 329 | 3 | 0.92% |
Dec 31, 2017 | 326 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
QuidelOrtho | 7,100 |
Premier | 2,800 |
Neogen | 2,640 |
PTC Therapeutics | 995 |
PROCEPT BioRobotics | 626 |
Merus | 229 |
Celldex Therapeutics | 160 |
Arcellx | 130 |
MOR News
- 3 days ago - MorphoSys AG Reports First Quarter 2024 Financial Results - Business Wire
- 3 days ago - Morphosys says Novartis takeover progressing as planned for H1 2024 - Reuters
- 8 days ago - MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting - Accesswire
- 21 days ago - MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis - Accesswire
- 21 days ago - Novartis begins tender offer for MorphoSys - Reuters
- 21 days ago - Novartis tender offer for MorphoSys AG commences - GlobeNewsWire
- 5 weeks ago - MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act - Accesswire
- 7 weeks ago - MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - Business Wire